FTC warns drugmakers over improper patent filings – STAT – STAT
FTC warns drugmakers over improper patent filings – STAT STAT
PATENT NEWS
-
In: PATENT NEWS
-
In: PATENT NEWS
Verisign’s Digital Money Supported Patent Reforms Space Name … – cryptonewsbytes.com
Verisign’s Digital Money Supported Patent Reforms Space Name … cryptonewsbytes.com
-
In: PATENT NEWS
Treace Medical Concepts Announces New Patent Covering … – GlobeNewswire
Treace Medical Concepts Announces New Patent Covering … GlobeNewswire
-
In: PATENT NEWS
FTC, amid biopharma M&A drive, says it will take action against ‘sham’ patents – Fierce Pharma
The FTC has warned pharma companies that they could face legal action by making “improper” listings in the FDA’s Orange Book, a registry of …
-
In: PATENT NEWS
Parsing Biosciences Loses Patent-Infringement Lawsuit Against 10x Genomics and Stanford …
– Patent-eligible: Refers to subject matter that qualifies for protection under patent law. – Single-cell genomics: A technology that enables the …
-
In: PATENT NEWS
INDUSTRY INSIGHTS | In session: What to know about patent litigations in the UPC
To initiate an infringement action, the patent owner files a Statement of claim. The Statement includes facts, evidence, and legal argument …
-
In: PATENT NEWS
INDUSTRY INSIGHTS | In session: What to know about patent … – LEDs Magazine
INDUSTRY INSIGHTS | In session: What to know about patent … LEDs Magazine
-
In: PATENT NEWS
Reps. Fitzgerald, Gallagher, Issa, Luetkemeyer: Intro bill to prohibit … – WisPolitics.com
Reps. Fitzgerald, Gallagher, Issa, Luetkemeyer: Intro bill to prohibit … WisPolitics.com
-
In: PATENT NEWS
Tomasz Targosz > Traple Konarski Podrecki & Partners > Warsaw > Poland | Lawyer Profile
Specialises in intellectual property cases, in particular in disputes concerning copyright and related rights as well as patent law and in unfair …
-
In: PATENT NEWS
The Interplay: Key Decisions at the Intersection of Antitrust & Life Sciences – September 2023
… intellectual property law—and the intersection between the two. … Patent Act. While the FTC argued that the 2017 agreement was an illegal …